|
Axontherapix Parkinson's Disease is one of the most common neurodegenerative diseases but a definitive treatment has not yet been developed. Axontherapix is developing, jointly with Dr. Lopez Barneo’s laboratory, a cell therapy treatment for this disease. |
 |